Rare Elizabethkingia meningosepticum meningitis case in an immunocompetent adult

被引：13

作者：

Hayek, Salim S. ^{[1
]}

Abd, Thura T. ^{[1
]}

Cribbs, Sushma K. ^{[2
]}

Anderson, Albert M. ^{[3
]}

Melendez, Andre ^{[3
]}

Kobayashi, Miwako ^{[3
]}

Polito, Carmen ^{[2
]}

Wang, Yun F. ^{[4
,5
]}

机构：

[1] Emory Univ, Sch Med, Dept Med, J Willis Hurst Internal Med Residency Program, Atlanta, GA 30303 USA

[2] Emory Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30303 USA

[3] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30303 USA

[4] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30303 USA

[5] Grady Mem Hosp, Clin Lab, Atlanta, GA 30303 USA

来源：

EMERGING MICROBES & INFECTIONS | 2013年 / 2卷

关键词：

chryseobacterium; Elizabethkingia meningosepticum; flavobacterium; meningitis; MALDI-TOF mass spectrometry; Vitek; FLAVOBACTERIUM-MENINGOSEPTICUM; CHRYSEOBACTERIUM-MENINGOSEPTICUM; MASS-SPECTROMETRY; BACTERIA; SUSCEPTIBILITY; SEPSIS;

D O I：

10.1038/emi.2013.16

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Though Elizabethkingia meningosepticum typically causes meningitis in neonates, its occurrence in adult is rare, with sixteen cases described worldwide. We report a case of E. meningosepticum meningitis in an immunocompetent adult. Bacterial identification was made a day earlier than conventional method by using matrix assisted laser desorption ionization time-of-flight (MALDI-TOF) Vitek mass spectrometry RUO (VMS), which resulted in successful treatment with rifampin, trimethoprim-sulfamethoxazole, levofloxacin and minocycline.

引用

页数：4

共 28 条

[1]

[Anonymous], 2011, Performance standards for antimicrobial disk susceptibility tests

[2]

approved standard M2-A11, V11th

[3] LATE FLAVOBACTERIUM SPECIES MENINGITIS AFTER CRANIOFACIAL EXENTERATION [J].

BAGLEY, DH ;

ALEXANDER, JC ;

GILL, VJ ;

DOLIN, R ;

KETCHAM, AS .

ARCHIVES OF INTERNAL MEDICINE, 1976, 136 (02) :229-231

[4]

Bascunana A, 1996, Enferm Infecc Microbiol Clin, V14, P394

[5]

Bernardet J.-F., 2006, The prokaryotes, P638, DOI [DOI 10.1007/0-387-30747-8_25, 10.1007/0-387-30747-825, DOI 10.1007/0-387-30747-825]

[6] Chryseobacterium meningosepticum: An emerging pathogen among immunocompromised adults - Report of 6 cases and literature review [J].

Bloch, KC ;

Nadarajah, R ;

Jacobs, R .

MEDICINE, 1997, 76 (01) :30-41

[7]

Bo Siri Hylleraas, 1995, Tidsskrift for den Norske Laegeforening, V115, P2646

[8] MALDI-TOF mass spectrometry tools for bacterial identification in clinical microbiology laboratory [J].

Carbonnelle, Etienne ;

Mesquita, Cecile ;

Bille, Emmanuelle ;

Day, Nesrine ;

Dauphin, Brunhilde ;

Beretti, Jean-Luc ;

Ferroni, Agnes ;

Gutmann, Laurent ;

Nassif, Xavier .

CLINICAL BIOCHEMISTRY, 2011, 44 (01) :104-109

[9] MENINGITIS CAUSED BY FLAVOBACTERIUM-MENINGOSEPTICUM AFTER TRANS-SPHENOIDAL HYPOPHYSECTOMY WITH RECOVERY [J].

CHAN, KH ;

CHAU, PY ;

WANG, RYC ;

HUANG, CY .

SURGICAL NEUROLOGY, 1983, 20 (04) :294-296

[10] FLAVOBACTERIUM-MENINGOSEPTICUM IN HOSPITAL ENVIRONMENT [J].

COYLEGILCHRIST, MM ;

CREWE, P ;

ROBERTS, G .

JOURNAL OF CLINICAL PATHOLOGY, 1976, 29 (09) :824-826

← 1 2 3 →